Plerixafor use for peripheral blood stem cell mobilization in Korea-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plerixafor use for peripheral blood stem cell mobilization in Korea

Published:2013 Issue:2 Volume:48 Page:72
ISSN:2287-979X
Container-title:Blood Research
language:en
Short-container-title:Blood Res

Author:

Kim Seok Jin¹,Yoon Dok Hyun²,Yang Deok-Hwan³,Eom Hyeon Seok⁴,Cho Seok Goo⁵,Yoon Sung-Soo⁶,Lee Jae Hoon⁷,Kim Won Seog¹,Suh Cheolwon²

Affiliation:

1. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

2. Department of Oncology, Asan Medical Center, University of Ulsan, Seoul, Korea.

3. Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Korea.

4. Hematologic Malignancy Branch, National Cancer Center, Ilsan, Korea.

5. Department of Internal Medicine, St. Mary Hospital, The Catholic University of Korea, Seoul, Korea.

6. Department of Internal Medicine, Seoul National University Hospiltal, Seoul, Korea.

7. Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.

Publisher

The Korean Society of Hematology

Subject

Hematology

Link

https://synapse.koreamed.org/pdf/10.5045/br.2013.48.2.72

Reference5 articles.

1. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

2. Poor Mobilization of Peripheral Blood Stem Cells is a Risk Factor for Worse Outcome in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

3. Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

4. Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo

5. Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plerixafor use in autologous hematopoietic stem cell mobilization: Experience from a single center in Southern India;Asian Journal of Transfusion Science;2022

2. Hematopoietic stem cell mobilization: current status and future perspective;Blood Research;2017

3. Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF;Leukemia & Lymphoma;2015-11-16

4. High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma;Bone Marrow Transplantation;2015-06-22

5. CXCR4+ granulocytes reflect fungal cystic fibrosis lung disease;European Respiratory Journal;2015-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3